University of California Scientist Wins Barancik Prize for Innovation in MS Research

Professor Katerina Akassoglou to receive 2018 Prize for work understanding the origins of nerve damage in MS and identifying potential therapies to stop it.
21-Jan-2019 3:05 PM EST Add to Favorites

Tailored Disability-Specific Neuroprotective Treatment Development in MS Offers a Potential New Approach

Dr. Rhonda Voskuhl professor at the University of California, Los Angeles, will present her hypothesis that molecular mechanisms underlying each disability may differ from each other based on regional differences in neurons, astrocytes and...
27-Nov-2018 4:55 PM EST Add to Favorites

Precision medicine approaches for multiple sclerosis will be featured at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2019 Forum

Fourth annual Forum will be held Feb. 28-March 2 in Dallas, Texas.
1-Nov-2018 12:05 PM EDT Add to Favorites

ACTRIMS Recognizes Young Investigators at Forum 2018

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) recognized the research contributions of five young investigators during the recent ACTRIMS Forum 2018. Abstracts and posters can be found in the ACTRIMS Forum online...
26-Feb-2018 12:05 PM EST Add to Favorites

Barancik Prize To Be Presented at ACTRIMS Forum 2018

Professor Robin Franklin to receive the 2017 Barancik Prize for pioneering work to restore function for people with progressive MS. He will receive the award at ACTRIMS Forum 2018 on February 1 in San Diego, California.
14-Dec-2017 12:05 PM EST Add to Favorites

Suhayl Dhib-Jalbut, M.D., to Present Findings in Keynote Address at ACTRIMS Forum 2018

New findings uncover the mechanisms by which gut bacteria can trigger inflammation in the brain and contribute to multiple sclerosis
30-Nov-2017 2:05 PM EST Add to Favorites

Therapeutic Targets in Multiple Sclerosis Will Be Featured at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2018 Forum

ACTRIMS' third annual forum will be Feb. 1-3 in San Diego, California and will focus on therapeutic targets in multiple sclerosis with emphasis on disease-modifying therapies. New at the 2018 forum is the presentation by the National Multiple...
11-Aug-2017 10:05 AM EDT Add to Favorites

ACTRIMS Recognizes Young Investigators at Forum 2017

Abstracts from Environmental Factors, Genetics and Epigenetics in MS Susceptibility and Clinical Course are now available at Multiple Sclerosis Journal.
9-Mar-2017 10:05 AM EST Add to Favorites

see all news